Drug Shortage Report for SODIUM PHOSPHATES INJECTION USP

Last updated on 2022-03-10 History
Report ID 143043
Drug Identification Number 00896187
Brand name SODIUM PHOSPHATES INJECTION USP
Common or Proper name SODIUM PHOSPHATES
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) SODIUM PHOSPHATE DIBASIC SODIUM PHOSPHATE MONOBASIC
Strength(s) 268MG 276MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 10 X 10ML
ATC code B05XA
ATC description I.V. SOLUTION ADDITIVES
Reason for shortage Shortage of an active ingredient.
Anticipated start date
Actual start date 2021-07-26
Estimated end date 2022-01-31
Actual end date 2022-01-26
Shortage status Resolved
Updated date 2022-03-10
Company comments Will be backorder starting from early January until the release date
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v21 2022-03-10 English Compare
v20 2022-01-27 French Compare
v19 2022-01-27 English Compare
v18 2022-01-13 English Compare
v17 2021-12-22 French Compare
v16 2021-12-22 English Compare
v15 2021-12-01 French Compare
v14 2021-12-01 English Compare
v13 2021-11-29 French Compare
v12 2021-11-29 English Compare
v11 2021-11-24 French Compare
v10 2021-11-24 English Compare
v9 2021-09-15 French Compare
v8 2021-09-15 English Compare
v7 2021-09-14 French Compare
v6 2021-09-14 English Compare
v5 2021-07-27 English Compare
v4 2021-07-26 French Compare
v3 2021-07-26 English Compare
v2 2021-07-26 French Compare

Showing 1 to 20 of 21